Study of rhinocerebral zygomycosis in an only partially compliant patient

被引：0

作者：

Gruber, I. ^{[1
]}

Lackinger, B. ^{[2
]}

机构：

[1] Landesklinikum Wiener Neustadt, Abt Augenheilkunde & Optometrie, A-2700 Wiener Neustadt, Austria

[2] Landesklinikum St Polten, Abt Augenheilkunde & Orbitachirurg, St Polten, Austria

来源：

SPEKTRUM DER AUGENHEILKUNDE | 2010年 / 24卷 / 03期

关键词：

Zygomycosis; mucormycosis; rhinocerebral; compliance; cavernous sinus thrombosis; ocular invasion; FUNGAL-INFECTIONS; MUCORMYCOSIS; POSACONAZOLE; PATHOGENESIS; MANAGEMENT;

D O I：

10.1007/s00717-010-0400-3

中图分类号：

R77 [眼科学];

学科分类号：

100212 ;

摘要：

BACKGROUND: Short description of the pathogenicity of zygomycetes. PATIENT AND METHODS: The patient was observed both clinically and by MRI over a period of two years, starting with the first presentation. RESULTS: Description of the applied and rejected diagnostic and therapeutic options and their results. CONCLUSION: In spite of repeated interruptions of treatment the patient was able to maintain a subjective high quality of life over a period of two years. Visual acuity of the right eye amounts to 1.0 s.c., the left eye became blind one week after the first presentation.

引用

页码：162 / 165

页数：4

共 15 条

[1]

BROWN J, 2005, AM J HLTH SYSTE 1221

[2] Posaconazole as salvage therapy for zygomycosis [J].

Greenberg, RN ;

Mullane, K ;

van Burik, JAH ;

Raad, I ;

Abzug, MJ ;

Anstead, G ;

Herbrecht, R ;

Langston, A ;

Marr, KA ;

Schiller, G ;

Schuster, M ;

Wingard, JR ;

Gonzalez, CE ;

Revankar, SG ;

Corcoran, G ;

Kryscio, RJ ;

Hare, R .

ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 2006, 50 (01) :126-133

[3] The iron chelator deferasirox protects mice from mucormycosis through iron starvation [J].

Ibrahim, Ashraf S. ;

Gebermariam, Teclegiorgis ;

Fu, Yue ;

Lin, Lin ;

Husseiny, Mohamed I. ;

French, Samuel W. ;

Schwartz, Julie ;

Skory, Christopher D. ;

Edwards, John E., Jr. ;

Spellbergl, Brad J. .

JOURNAL OF CLINICAL INVESTIGATION, 2007, 117 (09) :2649-2657

[4] Iron acquisition: a novel perspective on mucormycosis pathogenesis and treatment [J].

Ibrahim, Ashraf S. ;

Spellberg, Brad ;

Edwards, John, Jr. .

CURRENT OPINION IN INFECTIOUS DISEASES, 2008, 21 (06) :620-625

[5] Predictors of mortality in rhinocerebral mycosis [J].

Jayalakshmi, Sita S. ;

Reddy, Ramana G. ;

Borgohain, Rupam ;

Subramanyam, C. ;

Panigrahi, Manas ;

Sundaram, C. ;

Meena, A. K. ;

Mohandas, S. .

NEUROLOGY INDIA, 2007, 55 (03) :292-297

[6] Development of Effective Ocular Preparations of Antifungal Agents [J].

Kaur, Indu Pal ;

Rana, Cheena ;

Singh, Harinder .

JOURNAL OF OCULAR PHARMACOLOGY AND THERAPEUTICS, 2008, 24 (05) :481-493

[7] Invasive zygomycosis: Update on pathogenesis, clinical manifestations, and management [J].

Kontoyiannis, Dimitrios P. ;

Lewis, Russell E. .

INFECTIOUS DISEASE CLINICS OF NORTH AMERICA, 2006, 20 (03) :581-+

[8]

Lai Chih-Cheng, 2008, Journal of Infection and Chemotherapy, V14, P77, DOI 10.1007/s10156-007-0595-7

[9] Current options in antifungal pharmacotherapy [J].

Mohr, John ;

Johnson, Melissa ;

Cooper, Travis ;

Lewis, James S. ;

Ostrosky-Zeichner, Luis .

PHARMACOTHERAPY, 2008, 28 (05) :614-645

[10]

Pak Jane, 2008, J Emerg Trauma Shock, V1, P106, DOI 10.4103/0974-2700.42203

← 1 2 →